Riskpilot← Back to searchSign inGet full accessMEDECT CLINICAL TRIALS AB
ABActiveOrg 5568850605StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20121 employees
Revenue 2024
SEK 32K
-92% vs 2023
EBITDA margin
-6953.1%
+19% vs 2023
Equity ratio
35.2%
Financial strength
Net profit 2024
SEK 1K
-50% vs 2023
| Revenue | SEK 32K | -92% |
| EBITDA | SEK -2,2M | +19% |
| Net profit | SEK 1K | -50% |
| Total assets | SEK 574K | -49% |
| Equity | SEK 202K | +0% |
| Employees | 1 | — |
Legal name
MEDECT CLINICAL TRIALS AB
Org number
5568850605
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 februari 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av Alexanderson, Peter Erik Bragée, Björn Anders Bragée, Britt Karin Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva uppdragsforskning inom medicin och sjukvård, it-verksamhet, utbildning inom området samt därmed förenlig verksamhet.
Address
Stockholm
Phone
+46854588875
Email
info@bragee.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 61 | 632 | 228 | 413 | 32 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 239 | −3 313 | −3 330 | −2 738 | −2 225 |
| Depreciation & amort. | −0 | −5 | −20 | −20 | −20 |
| EBIT | −8 239 | −3 318 | −3 350 | −2 758 | −2 245 |
| Net financials | — | — | — | 3 | 2 |
| Profit before tax | 1 | 0 | 0 | 2 | 1 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | 0 | 0 | 2 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 960 | 893 | 885 | 1 131 | 574 |
| Equity | 199 | 200 | 200 | 201 | 202 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 761 | 694 | 685 | 930 | 372 |
| Total debt | 761 | 694 | 685 | 930 | 372 |
EBITDA margin
-6953.1%
This company
15.8%
Market median
-44107% vs market
20202024
Equity ratio
35.2%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
0.5%
This company
18.4%
Market median
-97% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
1.84×
This company
0.62×
Market median
-197% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PE Chief Executive Officer | Chief Executive Officer | 2022 |
ÅS Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
JS Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Former (5) | ||
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Chairman | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BRAGEE KLINIKER AB
MEDECT CLINICAL TRIALS AB Board members of MEDECT CLINICAL TRIALS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Erik Alexanderson | Chief Executive Officer | 0 companies |
| Åsa Sofia Thelin | Chief Auditor | 0 companies |
| John Samuel Peter Osser | Chief Auditor | 0 companies |
| Ingrid Sofia Alexanderson | Board of Directors | 0 companies |
| Axel Gunnar Welander | Board of Directors | 0 companies |
| Susanna Åhs | Board of Directors | 0 companies |
| Björn Anders Bragée | Chairman | 0 companies |
| Britt Karin Bragée | Board of Directors | 0 companies |
| Bo Lennart Ljungh | Board of Directors | 0 companies |
| Mats Gunnar Törnquist | Chairman | 0 companies |